Optima MedycynaS.A.

General medical practice activities

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2007-03-01
Share capital
992 704,00 PLN
Activity description

Optima Medycyna is a company that offers advanced laser treatments using the Fotona Spectro SP technology, focusing on aesthetic medicine, dermatology, gynecology, and surgical procedures. They also provide online registration, e-prescriptions, and teleconsultations for patients. Additionally, they are involved in a grant project to support primary healthcare, funded by the European Regional Development Fund.

Registered address
ul. Niemodlińska 79, 45-864 Opole, Poland
Website
optima-medycyna.euWebsite active
Email
Email address current
Phone
Social media
Electronic delivery address
AE:PL-68166-45800-TIRJA-26

Financials

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 13.84mMedianUSD 755.07kAverageUSD 2.30m
Net profit
This companyUSD 2.07mMedianUSD 38.27kAverageUSD 140.90k
Operating costs
This companyUSD 11.40mMedianUSD 663.84kAverageUSD 2.11m
Assets
This companyUSD 13.13mMedianUSD 257.71kAverageUSD 1.49m

Bank accounts

Registered as a VAT taxpayer on 1994-12-19. Active

  • Bank spółdzielczy
    Bank spółdzielczy
    59 8905 0000 2001 0021 7082 0002
  • Erste Bank Polska
    76 1090 2226 0000 0001 5013 1025
  • Bank spółdzielczy
    Bank spółdzielczy
    86 8905 0000 2001 0021 7082 0001

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

MSiG notices

Publication dateEvent
Jan 23, 2020Merger plan
Jul 28, 2016Call to creditors

Public aid

132 public aid cases recorded, with a total value of $516,343.

Grant datePurposeGross amountGranting body
Jul 2, 2026
Aid in the form of wage subsidies for employing workers with disabilities
$1,303Prezes Zarządu Państwowego Funduszu Rehabilitacji Osób Niepełnosprawnych
Jun 2, 2026
Aid in the form of wage subsidies for employing workers with disabilities
$1,459Prezes Zarządu Państwowego Funduszu Rehabilitacji Osób Niepełnosprawnych
Apr 28, 2026
Aid in the form of wage subsidies for employing workers with disabilities
$1,459Prezes Zarządu Państwowego Funduszu Rehabilitacji Osób Niepełnosprawnych

European Funds

StartProjectEU co-financingProgramme
2025-07-01
TERMOMODERNIZACJA BUDYNKU PRZYCHODNI LEKARSKIEJ SPÓŁKI OPTIMA MEDYCYNA
$113,932Fundusze Europejskie dla Nowoczesnej Gospodarki
2017-12-04
Wzrost wydajności i rozwój usług medycznych świadczonych w zakresie opieki nad dzieckiem poprzez remont i adaptację pomieszczeń w celu uruchomienia poradni pediatrycznej POZ w Optima Medycyna na ul. Dambonia 171 w Opolu
$171,812Regionalny Program Operacyjny Województwa Opolskiego 2014-2020

Tenders

No recorded participation in tenders.

Regulatory authorisations

AuthorityTypeStatus
BDO
BDO register entry Active

Authorized Representatives

Adam Szlęzak — President of the Management Board
Dominika Anna Świtała — Management Board Member
Piotr Ernest Jelitto — Vice President of the Management Board
Piotr Gustaw Straub — Attorney-in-fact (sole)

Manner of representation

1. The company is represented by: 1) in the case of a one-person management board, the President of the Management Board; 2) in the case of a two-person management board, each member of the management board independently; 3) in the case of a multi-member management board, each member of the management board independently, subject to property matters and incurring contractual obligations in an amount exceeding PLN 2,000,000.00 on a one-off basis, which require the joint action of two members of the management board or the action of a member of the management board together with a commercial proxy. 2. The rule referred to in point 1 subpoint 3 does not apply to the conclusion and amendment of agreements for the provision of healthcare services with the National Health Fund – the director of the relevant branch, or the legal successor of such entity. In such matters, each member of the management board may act independently, provided that the termination of such an agreement requires the joint action of two members of the management board or the action of a member of the management board together with a commercial proxy.

Supervisory board

Ernest Jelito — Supervisory Board Member
Maria Jadwiga Jelito — Supervisory Board Member
Victoria Kuharev — Supervisory Board Member

Beneficial owners

PersonRights
Katarzyna Maria Jelito (45)
Shareholder of a joint-stock company, 43.62%
Piotr Ernest Jelitto (39)
Shareholder of a joint-stock company, 43.62%

Subsidiaries

NameShare valueStake
13,506.21 USD100%
40,518.64 USD100%
28,633.17 USD100%

Competitors

Change history

DateEvent
2023-12-12Share capital change (887,070.00 PLN → 992,704.00 PLN)
2022-11-10PKD change (Removed: 47.75.Z; Added: 69.20.Z)
2020-04-06Address change (Głogowska 37, 45-315, Opole → Ul. Niemodlińska 79, 45-864, Opole)
2017-01-19Share capital change (934,000.00 PLN → 887,070.00 PLN)
2015-07-14PKD change (Removed: 17.23.Z, 18.12.Z, 33.12.Z, 41.10.Z, 42.11.Z, 47.19.Z, 47.54.Z, 47.61.Z, 47.62.Z, 49.39.Z, 49.41.Z, 58.11.Z, 58.12.Z, 58.13.Z, 58.14.Z, 58.19.Z, 58.29.Z, 61.10.Z, 61.20.Z, 61.30.Z, 61.90.Z, 62.01.Z, 62.02.Z, 62.03.Z, 62.09.Z, 63.11.Z, 63.12.Z, 63.99.Z, 64.20.Z, 64.92.Z, 64.99.Z, 65.12.Z, 65.20.Z, 68.32.Z, 69.20.Z, 70.10.Z, 70.21.Z, 70.22.Z, 71.11.Z, 71.12.Z, 71.20.B, 73.11.Z, 73.12.B, 73.12.C, 73.12.D, 73.20.Z, 74.10.Z, 74.90.Z, 77.33.Z, 77.39.Z, 77.40.Z, 79.11.A, 79.90.B, 81.10.Z, 82.30.Z, 82.99.Z, 85.59.B, 85.60.Z, 86.90.A, 86.90.B, 86.90.D, 87.10.Z, 87.20.Z, 87.30.Z, 87.90.Z, 88.10.Z, 88.91.Z, 88.99.Z, 95.11.Z)

FAQ

Last updated: 2026-07-09